RT Journal Article
SR Electronic
T1 A population framework for predicting the proportion of people infected by the far-field airborne transmission of SARS-CoV-2 indoors
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.11.24.21266807
DO 10.1101/2021.11.24.21266807
A1 Christopher Iddon
A1 Benjamin Jones
A1 Patrick Sharpe
A1 Muge Cevik
A1 Shaun Fitzgerald
YR 2021
UL http://medrxiv.org/content/early/2021/11/24/2021.11.24.21266807.abstract
AB The number of occupants in a space influences the risk of far-field airborne transmission of the SARS-CoV-2 virus because the likelihood of having infectious and susceptible people both scale with the number of occupants. Mass-balance and dose-response models determine far-field transmission risks for an individual person and a population of people after sub-dividing a large reference space into 10 identical comparator spaces.For a single infected person when the per capita ventilation rate is preserved, the dose received by an individual person in the comparator space is 10-times higher because the equivalent ventilation rate per infected person is lower.However, accounting for population dispersion, such as the community infection rate, the probability of an infected person being present and uncertainty in their viral load, shows the probability of transmission increases with occupancy. Also, far-field transmission is likely to be a rare event that requires a set of Goldilocks conditions that are just right, when mitigation measures have limited effect.Therefore, resilient buildings should deliver the equivalent ventilation rate required by standards and increase the space volume per person, but also require reductions in the viral loads and the infection rate of the wider population.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors acknowledge the Engineering and Physical Sciences Research Council (EP/W002779/1) who financially supported this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript and Supplemental MaterialsĪmean number of infected people presentmean dose in a space where one infected personis presentĪmean number of infected people in a space that contains a potential transmission eventmean individual probability of infection occurring in a scenariomean individual infection risk that occurs in all potential transmission scenariosϕtotal removal rate (s−1)Ccommunity infections rate (%)Ddose (viable virions)Gemission rate of RNA copies (RNA copies s−1)Inumber of infected peopleKfraction of aerosol particles absorbed by respiratory tractkreciprocal of the probability that a single pathogen initiates an infectionLviral load (RNA copies per ml of respiratory fluid)Nnumber of occupantsNsnumber of susceptible people exposedNs(I)number of susceptible people exposed in spaces that contain I infected peopleNtnumber of transmissions in the entire populationNt(I)number of transmissions that occur in spaces that contain I infected peopleNpoppopulation sizeP (0 < I < N)probability of a space containing a potential transmissionP (I)probability of I infected people presentP (L)probability of a viral loadP (R)individual probability of infectionP (S)probability of a person being both susceptible and exposed to the virusqsussusceptible person respiratory rate (m3 s−1)Texposure period (s)Vspace volume (m3)υviable fraction